Disparate spinal and supraspinal opioid antinociceptive responses in β-endorphin-deficient mutant mice

Neuroscience

Volumn 101, Issue 3, 2000, Pages 709-717

  Mogil, J S ^a   Grisel, J E ^b   Hayward, M D ^c   Bales, J R ^b   Rubinstein, M ^d   Belknap, J K ^c   Low, M J ^c  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b FURMAN UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

Author keywords

receptor; Analgesia; Knockout; Morphine; Transgenic mice

Indexed keywords

BETA ENDORPHIN; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENOTYPE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SPINAL CORD; TRANSGENIC MOUSE;

ANALGESICS, OPIOID; ANIMALS; BETA-ENDORPHIN; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; EFFERENT PATHWAYS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHINE; NEURONS; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; RADIOLIGAND ASSAY; SPINAL CORD;

EID: 0034669059     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00422-X     Document Type: Article

References (47)

1. Where are the mu receptors that mediate opioid analgesia? An autoradiographic study in the HAR and LAR selection lines
2. Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice
3. Naloxone alters pain perception and somatosensory evoked potentials in normal subjects
4. Strategies for studying opioid peptide regulation at the gene, message and protein levels
5. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
6. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide
7. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ
8. Intrathecal morphine in mice: a new technique
9. Quantitative autoradiographic mapping of μ-, δ- and κ-opioid receptors in knockout mice lacking the μ-opioid receptor gene
10. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
11. Intracerebroventricular injections in mice: some methodological refinements
12. Endorphin is a potent analgesic agent
13. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
14. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype
15. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor
16. Multiple opioid systems and pain
17. Transgenic studies of pain
18. Orphanin FQ is a functional anti-opioid peptide
19. Mu-opiate receptor binding is up-regulated in mice selectively bred for high stress-induced analgesia
20. The genetics of pain and pain inhibition
21. Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred mouse strains: implications for transgenic knock-out studies
22. Heritability of nociception. I. Responses of eleven inbred mouse strains on twelve measures of nociception
23. 2, and delta opioid binding in the central nervous system of C57BL/6BY and CXBK (opioid receptor-deficient) mice
24. Evidence for the existence of the β-endorphin-sensitive 'ε-opioid receptor' in the brain: the mechanisms of ε-mediated antinociception
25. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat
26. Pharmacological mechanisms of opioid analgesics
27. Different receptor subtypes mediate spinal and supraspinal analgesia in mice
28. Orphanin FQ: a novel neuropeptide which is a natural ligand of an opioid-like G protein-coupled receptor
29. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites
30. Absence of opioid stress-induced analgesia in mice lacking β-endorphin by site-directed mutagenesis
31. 1 opioid receptors in κ-opioid receptor knockout mice
32. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia
33. Intrathecal β-funaltrexamine antagonizes intracerebroventricular β-endorphin- but not morphine-induced analgesia in mice
34. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamine-treated mice
35. 2-opioid receptors in the brain and spinal cord, respectively
36. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of rat
37. Differential actions of intrathecal naloxone on blocking the tail-flick inhibition induced by intraventricular β-endorphin and morphine in rats
38. Endorphin as a potent analgesic by intravenous injection
39. Different mechanisms mediate β-endorphin- and morphine-induced inhibition of the tail-flick response in rats
40. Spinal opiate analgesia: characteristics and principles of action
41. Narcotic analgesics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques
42. Nociceptin/orphanin FQ: role in nociceptive information processing
43. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine
44. Nociceptive stimulus induces release of endogenous β-endorphin in the rat brain